Cargando…
Dose constraints for whole breast radiation therapy based on the quality assessment of treatment plans in the randomised Danish breast cancer group (DBCG) HYPO trial
PURPOSE: Quality assessment of the treatment plans in the Danish Breast Cancer Group (DBCG) HYPO trial was carried out based on prospectively reported dosimetric parameters and evidence-based dose constraints for whole breast radiation therapy were derived. MATERIALS AND METHODS: From 2009 to 2014,...
Autores principales: | Thomsen, M.S., Berg, M., Zimmermann, S., Lutz, C.M., Makocki, S., Jensen, I., Hjelstuen, M.H.B., Pensold, S., Hasler, M.P., Jensen, M.-B., Offersen, B.V. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8079332/ https://www.ncbi.nlm.nih.gov/pubmed/33937532 http://dx.doi.org/10.1016/j.ctro.2021.03.009 |
Ejemplares similares
-
Does timing of adjuvant chemotherapy influence the prognosis after early breast cancer? Results of the Danish Breast Cancer Cooperative Group (DBCG)
por: Cold, S, et al.
Publicado: (2005) -
Selection criteria for early breast cancer patients in the DBCG proton trial – The randomised phase III trial strategy
por: Stick, Line Bjerregaard, et al.
Publicado: (2021) -
Predicting efficacy of epirubicin by a multigene assay in advanced breast cancer within a Danish Breast Cancer Cooperative Group (DBCG) cohort: a retrospective-prospective blinded study
por: Buhl, Anna Sofie Kappel, et al.
Publicado: (2018) -
Neoadjuvant chemotherapy and HER2 dual blockade including biosimilar trastuzumab (SB3) for HER2-positive early breast cancer: Population based real world data from the Danish Breast Cancer Group (DBCG)
por: Berg, Tobias, et al.
Publicado: (2020) -
Carbonic anhydrase IX and response to postmastectomy radiotherapy in high-risk breast cancer: a subgroup analysis of the DBCG82 b and c trials
por: Kyndi, Marianne, et al.
Publicado: (2008)